News & Updates
Infant Botulism Outbreak Linked to Infant Formula
The CDC is working with multiple partners including state public health departments, clinicians, laboratories, and the Food and Drug Administration (FDA) to investigate a multistate outbreak of infant botulism. At...
Pertussis in Nevada, Recommendations for Health Care Providers
Summary Thus far in 2025, health authorities in Nevada are observing upticks of pertussis activity in some parts of the state. Pertussis (also known as whooping cough) is a contagious...
Updates to NRS 442.010, Rapid Point-of-Care Syphilis Testing During Pregnancy
Summary Assembly Bill (AB) 360, introduced by Assemblymember Heather Goulding, was approved and signed by Governor Lombardo May 30, 2025, as part of the 83rd Nevada Legislative Session. The amendments...
Proposed Changes to Nevada Administrative Code Chapters 441A (LCB File No. R174-24)
Please be advised that in light of the ongoing State network issues, the public workshop to consider amendments to Nevada Administrative Code (NAC Chapter 441A) scheduled for Wednesday, August 27,...
Measles in the United States, Recommendations for Health Care Providers
Summary Measles (rubeola) activity in the United States is increasing with several outbreaks as well as several imported cases. On March 7, 2025, CDC released a Health Alert Network (HAN)...
Nevada State Public Health Laboratory Guidance for Tuberculosis and Bacillus Testing
Background The purpose of this technical bulletin is to provide guidance on two Nevada State Public Health Laboratory (NSPHL) specimen/isolate submission updates: 1) Mycobacterium tuberculosis (MTB) rapid test utilizing the...
Accelerated Testing and Surveillance for Avian Influenza A (H5N1) Human Cases
Background Avian influenza A (H5N1) has been circulating widely among birds and mammals in the United States since 2022. In spring 2024, H5N1 was detected in dairy cattle for the...
FDA Approves and Authorizes for Emergency Use Updated COVID-19 Vaccines and De-authorizes Administration of 2023-2024 COVID-19 Vaccines – Update to Recommendation
Background On August 22, 2024, the U.S. Food and Drug Administration (FDA) issued approval and granted emergency use authorization (EUA) to both Moderna and Pfizer-BioNTech for their updated mRNA COVID-19...
Clinician Guidance for Acute Flaccid Myelitis (AFM)
As the winter season approaches, an increase in the circulation of respiratory pathogens, including enteroviruses, is expected. Enterovirus D-68 (EV-D68) is believed to be the main enterovirus responsible for the...
Minor Consent for Sexually Transmitted Disease Prevention and Treatment Services
Background Prior to the passage of SB 172, Nevada Revised Statute (NRS) 430A.180 excluded providers from being able to provide minors certain medical services, including STD treatment, if the provider...
Blood Lead Level Testing in Nevada, Reporting Requirements
Background Lead is a naturally occurring heavy metal that can cause negative health effects in children and adults. Sources of lead exposure can include chipping or peeling paint in homes...
FDA Approves and Authorizes for Emergency Use Updated COVID-19 Vaccines and De- authorizes Administration of 2023-2024 COVID-19 Vaccines
Background On August 22, 2024, the U.S. Food and Drug Administration (FDA) issued approval and granted emergency use authorization (EUA) to both Moderna and Pfizer-BioNTech for their updated mRNA COVID-19...